Genscript Biotech Corporation (HKG: 1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.50
+0.68 (6.28%)
Nov 15, 2024, 4:08 PM HKT

Genscript Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-177.01-95.48-226.85-358.71-204.95-96.91
Upgrade
Depreciation & Amortization
76.6371.8561.1845.8632.3320.36
Upgrade
Other Amortization
2.192.193.071.920.560.28
Upgrade
Loss (Gain) From Sale of Assets
0.780.690.770.911.110.15
Upgrade
Asset Writedown & Restructuring Costs
49.1411.6611.48-3.56-
Upgrade
Loss (Gain) From Sale of Investments
-4.84-2.433.64-0.53-1.8-1.04
Upgrade
Loss (Gain) on Equity Investments
2.421.380.03-0.60.31
Upgrade
Stock-Based Compensation
75.0860.5965.1539.6917.6410.78
Upgrade
Provision & Write-off of Bad Debts
6.274.781.150.93-0.641.85
Upgrade
Other Operating Activities
-128.6-255.25-204.38-9.5116.98-33.85
Upgrade
Change in Accounts Receivable
-3.09-116.9938.071.57-69.91-14.04
Upgrade
Change in Inventory
-10.36-3.93-19.53-15.14-14.97-8.42
Upgrade
Change in Accounts Payable
-3.78-37.0325.588.075.4315.93
Upgrade
Change in Unearned Revenue
83.89100.776.763.5431.48-0.11
Upgrade
Change in Other Net Operating Assets
11.4-29.74113.59144.631.4974.75
Upgrade
Operating Cash Flow
-19.89-286.91-120.29-136.79-151.09-29.96
Upgrade
Capital Expenditures
-253.26-252.45-216.11-133.04-121.88-110.37
Upgrade
Sale of Property, Plant & Equipment
0.310.240.090.270.060.36
Upgrade
Sale (Purchase) of Intangibles
-3.26-4.05-2.27-4.35-5.87-1.34
Upgrade
Investment in Securities
-781.39-101.72-219.75-82.4426.49-100.85
Upgrade
Other Investing Activities
1.360.25-5.257.021.043.56
Upgrade
Investing Cash Flow
-1,036-357.73-443.3-212.55-100.17-208.63
Upgrade
Long-Term Debt Issued
-74.3933.0626.0452.9227.25
Upgrade
Total Debt Issued
87.2774.3933.0626.0452.9227.25
Upgrade
Long-Term Debt Repaid
--34.06-7.39-74.94-30.6-20.41
Upgrade
Total Debt Repaid
-66.81-34.06-7.39-74.94-30.6-20.41
Upgrade
Net Debt Issued (Repaid)
20.4740.3325.67-48.8922.336.84
Upgrade
Issuance of Common Stock
12.1417.65228.13951.23459.563.74
Upgrade
Repurchase of Common Stock
-----9.46-7.77
Upgrade
Other Financing Activities
21.211,010165.52-0.19-8.67-5.58
Upgrade
Financing Cash Flow
53.811,068419.32902.14624.2-2.78
Upgrade
Foreign Exchange Rate Adjustments
4.28-1.22-12.7-0.893.72-0.8
Upgrade
Net Cash Flow
-998.04422.4-156.97551.91376.66-242.16
Upgrade
Free Cash Flow
-273.15-539.36-336.41-269.83-272.97-140.33
Upgrade
Free Cash Flow Margin
-27.06%-64.25%-53.76%-55.06%-69.84%-51.33%
Upgrade
Free Cash Flow Per Share
-0.13-0.26-0.16-0.13-0.14-0.08
Upgrade
Cash Interest Paid
3.383.192.041.581.330.73
Upgrade
Cash Income Tax Paid
9.312.66-0.660.71-4.5318.83
Upgrade
Levered Free Cash Flow
-250.39-594.79-342.98-176.43-224.26-112.83
Upgrade
Unlevered Free Cash Flow
-232.1-577.6-334.69-174.95-223.37-112.34
Upgrade
Change in Net Working Capital
-85.52195.87-28.03-112.0418.32-50.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.